Atlas Trials

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Clinical trial NCT00534118 · COMPLETED

Trial details

NCT number
NCT00534118
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
LeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Start date
2003-10-01
Primary completion
2018-07-26
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.